Innovation

Receptor Linked Protein Tyrosine Phosphotases

Dana-Farber Cancer Institute
posted on 02/05/2009

Tyrosine phosphorylation is an important molecular switching mechanism that regulates a variety of cellular functions including cell proliferation, differentiation, and activation. Protein tyrosine phosphatases (PTPases) are critically involved in tyrosine phosphorylation; two conserved, intracellular phosphatase domains (D1 and D2) typify the receptor-type PTPases (RPTPases). This technology features methods for determining the three-dimensional structure of members of the RPTPase family. Accordingly, this invention provides the structure of the two domain Leukocyte Common Antigen Related D1/D2 protein (LAR). The invention also provides the structure of the cytoplasmic portion of CD45, the other prototypic member of the RPTPase family (in addition to LAR).

Applications/Advantages: Tyrosine phosphorylation is not only an essential part of signal transduction mediated by various growth factor receptors, but is also involved in intracellular signal transduction and nuclear cell cycle regulation. Disturbances of these processes are known to be causes of cancer. High quality crystallographic data reveals mechanistic information concerning tyrosine phosphorylation that in turn guides rational drug design. This technology provides the first high quality crystals and corresponding structural data concerning the membrane distal PTPase (D2) domain, and structures of the two consecutive PTPase domains within the same polypeptide chain. One may use the atomic coordinates to identify molecules that bind to CD45 and LAR. The crystallization methods for LAR and CD45 may prove especially valuable, as they can potentially be extrapolated to other protein tyrosine phosphatases.


Innovation Details
 

File Number: 780 

Other Information:

Investigator(s)
C Frederick

Contact
Nancy Grodin, Email Nancy_Grodin@dfci.harvard.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Tony delCampo at Dana-Farber Cancer Institute for more information.

Request more info via email request more info
People

Case Manager:

Tony  delCampo Tony delCampo

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Alfred R Berkeley, Chairman, Pipeline Financial Group, Inc., Former President and Vice Chairman, Nasdaq Stock Market, Inc.

"Our economy is inextricably intertwined with university innovations. Unfortunately, our country’s short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs..."  read more...